Microbot Medical Inc.

NASDAQ: MBOT · Real-Time Price · USD
3.07
-0.06 (-1.92%)
At close: Aug 15, 2025, 2:20 PM

Microbot Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-11.44M -10.74M -13.17M -11.31M
Depreciation & Amortization
91K 106K 102K 76K
Stock-Based Compensation
1.35M 1.39M 1.75M 1.39M
Other Working Capital
942K -11K -228K 497K
Other Non-Cash Items
234K 718K -7K n/a
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
942K -11K -228K 497K
Operating Cash Flow
-8.83M -8.53M -11.55M -9.35M
Capital Expenditures
-25K -33K -84K -69K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-5.12M -10.06M -3.75M n/a
Sales Maturities Of Investments
6.68M 12.06M n/a 3.27M
Other Investing Acitivies
n/a 3K -3K n/a
Investing Cash Flow
1.54M 1.97M -3.84M 3.2M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
7.94M 6.56M 4.32M n/a
Net Cash Flow
646K -2K -11.06M -6.15M
Free Cash Flow
-8.85M -8.57M -11.63M -9.42M